Characterization of the Contractile P2Y14 Receptor in Mouse Coronary and Cerebral Arteries ⇑ Kristian Agmund Haanes , Lars Edvinsson

Total Page:16

File Type:pdf, Size:1020Kb

Characterization of the Contractile P2Y14 Receptor in Mouse Coronary and Cerebral Arteries ⇑ Kristian Agmund Haanes , Lars Edvinsson FEBS Letters 588 (2014) 2936–2943 journal homepage: www.FEBSLetters.org Characterization of the contractile P2Y14 receptor in mouse coronary and cerebral arteries ⇑ Kristian Agmund Haanes , Lars Edvinsson Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Nordre Ringvej 59, 2600 Glostrup, Denmark article info abstract Article history: Extracellular UDP-glucose can activate the purinergic P2Y14 receptor. The aim of the present study Received 13 February 2014 was to examine the physiological importance of P2Y14 receptors in the vasculature. The data pre- Revised 13 May 2014 sented herein show that UDP-glucose causes contraction in mouse coronary and basilar arteries. Accepted 21 May 2014 The EC values and immunohistochemistry illustrated the strongest P2Y14 receptor expression in Available online 6 June 2014 50 the basilar artery. In the presence of pertussis toxin, UDP-glucose inhibited contraction in coronary Edited by Ned Mantei arteries and in the basilar artery it surprisingly caused relaxation. After organ culture of the coro- nary artery, the EC50 value decreased and an increased staining for the P2Y14 receptor was observed, showing receptor plasticity. Keywords: Purinergic receptors Ó 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. P2Y14 Coronary artery Basilar artery Receptor upregulation P2Y2 KO 1. Introduction vasoconstriction in porcine pancreatic arteries [12]. This study was designed to examine the physiological importance of the Nucleotides are extracellular signal molecules that can activate P2Y14 receptor in the vasculature, specifically in the brain (basilar purinergic receptors in different tissues. There exist two main fam- artery) and heart (left anterior descending artery). Since UDP-glu- ilies of nucleotide-activated purinergic receptors: the P2X receptor cose has been shown to also activate P2Y2 receptors [13], experi- family of ligand-gated ion channels and the P2Y receptor family of ments were performed on wild type (WT) and on P2Y2 receptor G-protein coupled receptors [1]. Freemann and colleagues showed knock out (KO) mice [14]. that the orphan G-protein receptor GPR105 was activated by UDP- The A2A adenosine receptor acts through the stimulatory G-pro- glucose [2]. UDP-glucose can be released by cells, and thus extra- tein (Gs) and increases cellular cAMP levels leading to an endothe- cellular UDP-glucose can be present [3]. All signalling components lium independent relaxation [15]. We aimed to investigate whether for this receptor were present, and it was classified as a purinergic the P2Y14 receptor could be involved in smooth muscle contraction receptor and given the name P2Y14 [4]. Later, Fricks and colleagues via Gi activation and if it could be counteracted by the Gs relaxing showed that the intracellular pathway for the P2Y14 receptor is effect of adenosine. The experiments presented here show that coupled to the inhibitory G-protein (Gi) that inhibits the adenylyl the P2Y14 receptor is indeed a contractile receptor that is expressed cyclase, thereby lowering cellular cAMP levels [5]. in the cerebral and coronary arteries, and that the P2Y2 receptor The P2Y14 receptor is expressed widely in the body, e.g., in interference is minor. Organ culture of coronary artery segments brain, heart, skeletal muscles and spleen [6]. Most of the work so revealed enhanced expression of the P2Y14 receptor, demonstrat- far has been done on neutrophils where UDP-glucose is a chemo ing receptor plasticity. attractant [7–9]. Nucleotides have a well-established physiological role in vascular smooth muscle cells, where the purinergic recep- 2. Materials and methods tors modulate the contraction and relaxation [10,11]. Very recently, Alsaqati and colleagues reported that UDP-glucose elicited 2.1. Myography Mixed female and male BalbC mice (WT or P2Y2 KO [backcrossed for 7 generations]; 20 g, n = 52) were sedated with 70% CO2 in 30% ⇑ Corresponding author. Fax: +45 38633983. O and killed by decapitation. Heart and brain were immediately E-mail address: [email protected] (K.A. Haanes). 2 http://dx.doi.org/10.1016/j.febslet.2014.05.044 0014-5793/Ó 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. K.A. Haanes, L. Edvinsson / FEBS Letters 588 (2014) 2936–2943 2937 excised and placed into ice cold oxygenated calcium free physiolog- HPO4) overnight, followed by 25% sucrose for 24 h. The tissue was ical saline solution (Ca2+-free PSS) composed of (in mM): 119 NaCl, covered with tissue TEKÒ (Gibco) and sectioned at a thickness of 4.7 KCl, 2.5 CaCl2, 25 NaHCO3, 1.17 MgSO4, 1.18 KH2PO4, 5.5 glucose, 10 lm on a cryostat (Leica Microsystems GmBH, Germany). All sec- and 0.03 EDTA, pH 7.4. The LAD (left anterior descending) and basilar tions were blocked with 5% donkey serum (Jackson ImmunoRe- artery (segments length 2 mm) were dissected in ice cold, oxy- search Europe, Suffolk, UK) for 30 min, and incubated with genated Ca2+-free PSS and mounted on a Mulvany–Halpern wire primary antibodies directed against the P2Y14 receptor (rabbit myograph (Danish Myo Technology, Denmark). The myographs anti-GPR105/P2Y14, Ab136264, 1:200, Abcam, UK) in PBS contain- were connected to a PowerLab Unit and responses were sampled ing 1% BSA and 0.25% Triton X-100, overnight. Secondary antibody in LabChart™ (ADInstruments, UK). The mounted artery segments (Alexa Fluor 488, donkey anti-rabbit 1:400, Jackson ImmunoRe- were heated to 37 °C, and buffer changed for PSS with calcium. After search Europe, Suffolk, UK) was added after washing with PBS-Tri- 15 min equilibration, the vessels were stretched to their optimal ton X-100. Slides were mounted with Vectashield with DAPI. lumen diameter L1 = 0.9 Â L100, where L100 is an estimate of the Immunoreactivity was visualized and photographed with a Nikon diameter of the vessel under a passive transmural pressure 6 kPa microscope (EZ-c1, Germany), with the following filters: DAPI for the basilar artery and 9 kPa for the coronary arteries, in order (EX340-38, DM400, BA/EM435-485) and Alexa488 (EX465-495, to obtain optimal conditions for active tension development. Subse- DM505, BA/EM515-555). quently, the vessels were allowed to stabilize for 20–30 min. The vessels were kept at this standard tension during the entire period 2.5. Western blot in the myograph. To ensure a stable pH and bicarbonate concentra- tion at 25 mM (pH 7.40), all myograph baths were continuously bub- Dissected arteries were homogenized immediately, in boiling bled with 12% CO2 in 88% O2, to compensate for the large surface to SDS loading buffer (Expedeon, Kem-en-tec, Denmark), sonicated, volume ratio. frozen and re-sonicated before being heated to 70 °C for 10 min. The vascular smooth muscle cell contractile function was con- 10 ll of the sample was loaded into each well on a 4–20% gradient firmed by challenging the segments two times with 125 mM K+ gel. The proteins were transferred to PVDF membranes (GE Health- (KPSS, similar to PSS except that NaCl was exchanged for KCl on care, Denmark) using wet electroblotting. The membranes were an equimolar basis). All contractile responses are expressed as per- blocked overnight using 2% ECL™ Advance Blocking Agent (GE centage of the average maximal contraction induced by the K+ Healthcare, Denmark), incubated overnight at 4 °C in primary anti- response, with either normal baseline or PGF2a (Prostaglandin body solutions (rabbit anti-GPR105/P2Y14, Ab136264, 1:500 or goat F2a) contraction as baseline. The vessels where pre-contracted anti-SM22 1:2,000, both from Abcam, UK), washed briefly in TBS-T À6 À6 with 2 Â 10 M PGF2a for coronary arteries and 3 Â 10 M PGF2a (Tris buffered saline + 0.01% Tween-20) and then incubated with for cerebral arteries, producing about 50% of the contraction seen secondary antibody (ECL™ donkey anti rabbit 1:20,000, or DAKO À5 with 10 M PGF2a. This allows for fine tuning of the contractile donkey anti goat 1:2000) for 1.5 h at room temperature. Membranes response, e.g. by cAMP. All concentration response curves were were washed (5 Â 5 min in TBS-T) and developed using ECL™ Select made in a cumulative manner. Western Blotting Detection Kit (GE Healthcare, Denmark). Image capture was done using a LAS-1000 digital camera unit and quanti- 2.2. Endothelial influence fication using Multi gauge 3.2 (Fujifilm, Denmark). The addition of 10À5 M carbachol after precontraction by 2.6. Chemicals, data analyses and statistics À5 10 M PGF2a, was used to assess the endothelial function. The endothelium dependent carbachol effect value is expressed in %, All drugs and chemicals for myograph studies were acquired where 100% is a relaxation back to the baseline. The vessels used from Sigma–Aldrich, Germany. in this study are very small; therefore inserting the myograph wire Data were analysed using GraphPad Prism software (GraphPad will sometimes cause a partial or full removal of the endothelium. Software Inc., USA) and expressed as mean ± SEM (n equals the Since we have a varying degree of endothelium (determined by the number of animals). EC50 (or as negative logarithm: pEC50) repre- carbachol induced relaxation) we can correlate the amount of func- sents the agonist concentration required to produce 50% of the tional endothelium cells with an agonist induced contraction [16]. maximum response, calculated using non-linear regression. Where The influence of the endothelium on the Emax values of UDP-glu- no clear maximum contraction was observed, the max value was + cose was analysed by constructing a correlation curve of the Emax set to be 60% K ; this could lead to underestimates of the EC50 val- and the endothelium-dependent carbachol effect. ues. Paired and unpaired Student’s t-test was used to compare two groups.
Recommended publications
  • Protective Effects of Anthocyanins on the Ectonucleotidase Activity in the Impairment of Memory Induced by Scopolamine in Adult Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Life Sciences 91 (2012) 1221–1228 Contents lists available at SciVerse ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats Jessié M. Gutierres a,⁎, Fabiano B. Carvalho a, Maria R.C. Schetinger a, Marília V. Rodrigues a, Roberta Schmatz a, Victor C. Pimentel a, Juliano M. Vieira a, Michele M. Rosa a, Patrícia Marisco a, Daniela A. Ribeiro a, Claudio Leal a, Maribel A. Rubin a, Cinthia M. Mazzanti c, Roselia Spanevello b,⁎⁎ a Departamento de Química, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil b Centro de Ciências Químicas, Farmacêuticas e de Alimentos, Universidade Federal de Pelotas, Campus Universitário-Capão do Leão 96010-900 Pelotas, RS, Brazil c Clínica de Pequenos animais, Centro de Ciências Rurais, Universidade Federal de Santa Maria, Santa Maria, RS 97105-900, Brazil article info abstract Article history: Aims: We investigated whether the treatment with anthocyanins prevents the scopolamine-induced memory Received 24 March 2012 deficits and whether ectonucleotidase activities and purine levels are altered in the cerebral cortex (CC) and Accepted 19 September 2012 hippocampus (HC) in this model of mnemonic deficit in rats. Main methods: The animals were divided into 4 experimental groups: control (vehicle), anthocyanins (Antho), Keywords: scopolamine (SCO), and scopolamine plus anthocyanins (SCO+Antho). After seven days of treatment, they Anthocyanins were tested in the inhibitory avoidance task and open field test and submitted to euthanasia.
    [Show full text]
  • Ectonucleotidase Expression on Human Amnion Epithelial Cells
    Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations This information is current as of September 28, 2021. Fabio Morandi, Alberto L. Horenstein, Valeria Quarona, Angelo Corso Faini, Barbara Castella, Raghuraman C. Srinivasan, Stephen C. Strom, Fabio Malavasi and Roberto Gramignoli J Immunol published online 26 December 2018 Downloaded from http://www.jimmunol.org/content/early/2018/12/23/jimmun ol.1800432 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2018/12/23/jimmunol.180043 Material 2.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2018 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published December 26, 2018, doi:10.4049/jimmunol.1800432 The Journal of Immunology Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations Fabio Morandi,*,1 Alberto L. Horenstein,†,‡,x,1 Valeria Quarona,† Angelo Corso Faini,† Barbara Castella,† Raghuraman C.
    [Show full text]
  • Ectonucleotidase Activities in Sertoli Cells from Immature Rats
    Brazilian Journal of Medical and Biological Research (2001) 34: 1247-1256 Ectonucleotidases in Sertoli cells 1247 ISSN 0100-879X Ectonucleotidase activities in Sertoli cells from immature rats E.A. Casali, T.R. da Silva, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, D.P. Gelain, G.R.R.F. Kaiser, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil A.M.O. Battastini, J.J.F. Sarkis and E.A. Bernard Abstract Correspondence Sertoli cells have been shown to be targets for extracellular purines Key words E.A. Bernard such as ATP and adenosine. These purines evoke responses in Sertoli · Sertoli cells Departamento de Bioquímica · Purine nucleotides cells through two subtypes of purinoreceptors, P2Y2 and PA1. The Rua Ramiro Barcellos, 2600, Anexo · signals to purinoreceptors are usually terminated by the action of ATP diphosphohydrolase 90035-003 Porto Alegre, RS · Ecto-5’-nucleotidase ectonucleotidases. To demonstrate these enzymatic activities, we Brasil · Ectoadenosine deaminase Fax: +55-51-316-5540 cultured rat Sertoli cells for four days and then used them for different E-mail: [email protected] assays. ATP, ADP and AMP hydrolysis was estimated by measuring the Pi released using a colorimetric method. Adenosine deaminase activity (EC 3.5.4.4) was determined by HPLC. The cells were not disrupted after 40 min of incubation and the enzymatic activities were Received September 6, 2000 considered to be ectocellularly localized. ATP and ADP hydrolysis Accepted July 2, 2001 was markedly increased by the addition of divalent cations to the reaction medium. A competition plot demonstrated that only one enzymatic site is responsible for the hydrolysis of ATP and ADP.
    [Show full text]
  • P2X7 in Cancer: from Molecular Mechanisms to Therapeutics
    REVIEW published: 04 June 2020 doi: 10.3389/fphar.2020.00793 P2X7 in Cancer: From Molecular Mechanisms to Therapeutics Romain Lara 1*, Elena Adinolfi 2, Catherine A. Harwood 3, Mike Philpott 4, Julian A. Barden 5, Francesco Di Virgilio 6 and Shaun McNulty 1 1 Biosceptre (UK) Limited, Cambridge, United Kingdom, 2 Department of Medical Sciences, University of Ferrara, Ferrara, Italy, 3 Centre for Cell Biology and Cutaneous Research, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 4 Centre for Cutaneous Research, Blizard Institute, Bart’s & The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 5 Biosceptre (Australia) Pty Ltd., Sydney, NSW, Australia, 6 Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Ferrara, Italy P2X7 is a transmembrane receptor expressed in multiple cell types including neurons, dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of physiological responses from pain transduction to immune response. Upon activation by Edited by: its main ligand, extracellular ATP, P2X7 can form a nonselective channel for cations to Stefan Feske, enter the cell. Prolonged activation of P2X7, via high levels of extracellular ATP over an New York University, United States extended time period can lead to the formation of a macropore, leading to depolarization Reviewed by: Friedrich Haag, of the plasma membrane and ultimately to cell death. Thus, dependent on its activation University Medical Center Hamburg- state, P2X7 can either drive cell survival and proliferation, or induce cell death.
    [Show full text]
  • ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus Aureus Alpha-Toxin
    toxins Article ATP Release from Human Airway Epithelial Cells Exposed to Staphylococcus aureus Alpha-Toxin Romina Baaske, Mandy Richter, Nils Möller, Sabine Ziesemer, Ina Eiffler, Christian Müller and Jan-Peter Hildebrandt * Animal Physiology and Biochemistry, Ernst Moritz Arndt-University, Felix Hausdorff-Strasse 1, B.10.06, D-17489 Greifswald, Germany; [email protected] (R.B.); [email protected] (M.R.); [email protected] (N.M.); [email protected] (S.Z.); ina.eiffl[email protected] (I.E.); [email protected] (C.M.) * Correspondence: [email protected]; Tel.: +49-3834-86-4295; Fax: +49-3834-86-4261 Academic Editor: Vernon L. Tesh Received: 6 January 2016; Accepted: 1 December 2016; Published: 6 December 2016 Abstract: Airway epithelial cells reduce cytosolic ATP content in response to treatment with S. aureus alpha-toxin (hemolysin A, Hla). This study was undertaken to investigate whether this is due to attenuated ATP generation or to release of ATP from the cytosol and extracellular ATP degradation by ecto-enzymes. Exposure of cells to rHla did result in mitochondrial calcium uptake and a moderate decline in mitochondrial membrane potential, indicating that ATP regeneration may have been attenuated. In addition, ATP may have left the cells through transmembrane pores formed by the toxin or through endogenous release channels (e.g., pannexins) activated by cellular stress imposed on the cells by toxin exposure. Exposure of cells to an alpha-toxin mutant (H35L), which attaches to the host cell membrane but does not form transmembrane pores, did not induce ATP release from the cells.
    [Show full text]
  • Extracellular Adenosine Activates AMP-Dependent Protein Kinase (AMPK)
    1612 Research Article Extracellular adenosine activates AMP-dependent protein kinase (AMPK) Ivette Aymerich1, Fabienne Foufelle2, Pascal Ferré2, F. Javier Casado1 and Marçal Pastor-Anglada1* 1Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona, 08071 Barcelona, Spain 2Institut Biomédical des Cordeliers, U465 INSERM, Paris, France *Author for correspondence (e-mail: [email protected]) Accepted 4 January 2006 Journal of Cell Science 119, 1612-1621 Published by The Company of Biologists 2006 doi:10.1242/jcs.02865 Summary Adenosine monophosphate (AMP)-activated protein kinase AMPK activity. These effects are blocked by 5Ј- (AMPK) is a heterotrimeric complex that senses iodotubercidine (5Ј-ITU), an inhibitor of adenosine kinase. intracellular energy status and exerts rapid regulation on Moreover, inhibition of adenosine transport through the energy-demanding and -consuming metabolic pathways. concentrative adenosine plasma membrane transporter Although alterations in the intracellular adenosine CNT2 with formycin B results in the blockade of adenosine- nucleotide pool are traditionally assumed to be the mediated AMPK signaling. Extracellular adenosine is consequence of changes in energy metabolism, in this study equally able to activate AMPK and promote ACC we have addressed the question of whether extracellular phosphorylation in liver parenchymal cell models in a adenosine contributes to AMPK regulation. In the manner that is also inhibited by 5Ј-ITU. In summary, this intestinal rat epithelial cell line IEC-6, addition of study shows that adenosine, when added at physiological adenosine rapidly increases AMP intracellular concentrations, activates AMPK and promotes ACC concentrations and upregulates ␣1AMPK, thus promoting phosphorylation. Adenosine must be transported and phosphorylation of its downstream target acetyl-CoA phosphorylated to exert its action.
    [Show full text]
  • A Marker of Psychological Stress-Induced Immune Suppression
    2g-\\-9lc Lymphocytic 5' -Ectonucleotidase: A marker of psychological stress-induced immune suppression Jane Blake-Mortimer B.A. (Hons). M.Psych. (Adelaide) Thesis submitted in fulfilment of the requirements for the Degree of Doctor of Philosophy Department of Psychology The University of Adelaide July, 1996 Table of Contents Page List of Tables vlll List of Figures x Abstract xll Author's Statement xiv Acknowledgements xv Chapter 1: General Introduction 1 1.1 General overview 1 1.2 Definition of stress 2 1.3 Historical development of the field of 2 P sychoneuroimmunology t.4 The immune system: An overview 6 1.4.r Factors involved in the immune response 6 r.4.2 Innate immunity: The immediate response 6 r.4.3 Acquired immunity 9 r.4.4 T helper cell activation 10 1.4.5 The cell mediated response i0 t.4.6 The humoral response 11 1.5 The interactions between the neuroendocrine 15 and lymphoid systems 1.6 Methodological and conceptual issues 2T 1.6 i Defi nition of depresston 21 1 6.2 Characteristics of studies that have bedn 22 conducted to investigate the relationship between depression and immunity (i) Experimental design 22 (ii) Heterogeneityofdiagnosticclassification 22 (iii) Sampling 23 (iv) Severity of depression and hospitalisation 24 status ll Table of Contents Cont'd Page 1.6.3 Characteristics of studies that have been 24 conducted to investigate the relationship between psychological stress and immunity (i) Definition of stress and conceptual 24 problems (ii) Experimental design 25 (iii) Sampling 25 (iv) Lack of standardisation in the 26 stressors used and psychological measures (v) Methodological limitations of PNI 26 tests 1.7 A critique of the current tests commonly used 27 in PNI in humans t.7 .I Enumeration studies 27 t.7.2 Lectin or mitogenic responses 34 r.7.3 Natural killer cell activity 4I r.7 .4 Interleukins, enzymes, proteinases, acute phase 45 proteins and DNA expression during major depression 1.7 .5 Antibo dy (immuno globulin) measures 45 1.8 The effects of stress on humoral and cell-mediated 50 immunity in animals 1.8.
    [Show full text]
  • Purinergic Signalling in Neurodegeneration, Neuroprotection and Neuroregeneration
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery [Special Issue of Neuropharmacology entitled ‘Purines in Neurodegeneration and Neuroregeneration’. Guest Editors: Peter Illes, Alex Verkhratsky, Beata Sperlágh and Geoff Burnstock] An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration By Geoffrey Burnstock Autonomic Neuroscience Centre, University College Medical School, Rowland Hill Street, London NW3 2PF, UK. And Department of Pharmacology and Therapeutics, The University of Melbourne, Australia E-mail: [email protected] Tel: +44 20 7830 2948 Fax: +44 20 7830 2949 1 Introduction Trauma, ischaemia and stroke Neurodegenerative diseases Alzheimer's disease Parkinson's disease Huntington's disease Multiple sclerosis Amyotrophic lateral sclerosis Neuroprotection Neuroprotection against trauma, ischaemia and stroke Neuroprotection against neurodegenerative diseases Neuroregeneration: neural stem/progenitor cells Conclusions Abstract Purinergic signalling appears to play important roles in neurodegeneration, neuroprotection and neuroregeneration. Initially there is a brief summary of the background of purinergic signalling, including release of purines and pyrimidines from neural and non-neural cells and their ectoenzymatic degradation, and the current characterisation of P1 (adenosine), and P2X (ion channel) and P2Y (G protein-coupled) nucleotide receptor subtypes. There is also coverage of the localization and roles of purinoceptors in the healthy central nervous system. The focus is then on the roles of purinergic signalling in trauma, ischaemia, stroke and in neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases, as well as multiple sclerosis and amyotrophic lateral sclerosis. Neuroprotective mechanisms involving purinergic signalling are considered and its involvement in neuroregeneration, including the role of adult neural stem/progenitor cells.
    [Show full text]
  • Purinergic Signalling in the CNS Geoffrey Burnstock*
    24 The Open Neuroscience Journal, 2010, 4, 24-30 Open Access Purinergic Signalling in the CNS Geoffrey Burnstock* Autonomic Neuroscience Centre, University College Medical School, Rowland Hill Street, London NW3 2PF, UK Abstract: Purinergic neurotransmission, involving release of ATP as an efferent neurotransmitter was first proposed in 1972. Later it was recognised as a cotransmitter in peripheral nerves and more recently as a cotransmitter with glutamate, noradrenaline, GABA, acetylcholine and dopamine in the CNS. Both ion channel and G protein-coupled receptors for purines and pyrimidines are widely expressed in the brain and spinal cord. They mediate both fast signalling in neuro- transmission and neuromodulation and long-term (trophic) signalling in cell proliferation, differentiation and death. Purinergic signalling is prominent in neuron-glial cell interactions. Purinergic signalling has been implicated in learning and memory, locomotor activity and feeding behaviour. There is increasing interest in the involvement of purinergic sig- nalling in the pathophysiology of the CNS, including trauma, ischaemia, epilepsy, neurodegenerative diseases, neuropsy- chiatric and mood disorders. Keywords: ATP, adenosine, cotransmission, epilepsy, glia, memory, neurodegenerative diseases, purinoceptors, sleep. INTRODUCTION important being the P2U receptor, which could recognize pyrimidines such as uridine 5'-triphosphate (UTP) as well as The concept of purinergic neurotransmission was born in ATP [12]. Abbracchio and Burnstock [13], on the basis
    [Show full text]
  • Purinergic Signaling in the Hallmarks of Cancer
    cells Review Purinergic Signaling in the Hallmarks of Cancer Anaí del Rocío Campos-Contreras, Mauricio Díaz-Muñoz and Francisco G. Vázquez-Cuevas * Department of Cellular and Molecular Neurobiology, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Boulevard Juriquilla #3001, Juriquilla Querétaro 76230, Mexico; [email protected] (A.d.R.C.-C.); [email protected] (M.D.-M.) * Correspondence: [email protected]; Tel.: +52-(442)-238-1035 Received: 15 June 2020; Accepted: 2 July 2020; Published: 3 July 2020 Abstract: Cancer is a complex expression of an altered state of cellular differentiation associated with severe clinical repercussions. The effort to characterize this pathological entity to understand its underlying mechanisms and visualize potential therapeutic strategies has been constant. In this context, some cellular (enhanced duplication, immunological evasion), metabolic (aerobic glycolysis, failure in DNA repair mechanisms) and physiological (circadian disruption) parameters have been considered as cancer hallmarks. The list of these hallmarks has been growing in recent years, since it has been demonstrated that various physiological systems misfunction in well-characterized ways upon the onset and establishment of the carcinogenic process. This is the case with the purinergic system, a signaling pathway formed by nucleotides/nucleosides (mainly adenosine triphosphate (ATP), adenosine (ADO) and uridine triphosphate (UTP)) with their corresponding membrane receptors and defined transduction mechanisms. The dynamic equilibrium between ATP and ADO, which is accomplished by the presence and regulation of a set of ectonucleotidases, defines the pro-carcinogenic or anti-cancerous final outline in tumors and cancer cell lines. So far, the purinergic system has been recognized as a potential therapeutic target in cancerous and tumoral ailments.
    [Show full text]
  • (Rhamdia Quelen) Exposed to Different Salinities
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochemical Systematics and Ecology 46 (2013) 44–49 Contents lists available at SciVerse ScienceDirect Biochemical Systematics and Ecology journal homepage: www.elsevier.com/locate/biochemsyseco Ectonucleotidase and acetylcholinesterase activities in silver catfish (Rhamdia quelen) exposed to different salinities Alexssandro Geferson Becker a,*, Thaylise Vey Parodi a, Jamile Fabbrin Gonçalves c, Margarete Dulce Bagatini d, Roselia Maria Spanevello e, Vera Maria Morsch b, Maria Rosa Chitolina Schetinger b,c, Bernardo Baldisserotto a a Departamento de Fisiologia e Farmacologia, Universidade Federal de Santa Maria, Av. Roraima n 1000 – Cidade Univ, 97105-900 Santa Maria, RS, Brazil b Química, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil c Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, 90035-003 Porto Alegre, RS, Brazil d Colegiado do Curso de Enfermagem, Universidade Federal da Fronteira Sul, 89812-000 Chapecó, SC, Brazil e Centro de Ciências Químicas, Farmacêuticas e de Alimentos, Setor de Bioquímica, Universidade Federal de Pelotas, Campus Universitário Capão do Leão, 96010-900 Pelotas, RS, Brazil article info abstract Article history: The purpose of this study was to investigate whether salinity adaptation can alter the Received 8 April 2012 purinergic (ecto-nucleoside triphosphate diphosphohydrolase; NTPDase and, 50-nucleo- Accepted 8 September 2012 tidase) and cholinergic (acetylcholinesterase; AChE) systems in whole brain and blood Available online 4 October 2012 tissue of the silver catfish, Rhamdia quelen. Silver catfish were gradually adapted to salinities of 0, 4 or 8 ppt and maintained at the experimental salinity for 10 days before Keywords: brain and blood samples were collected.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0224110 A1 Bynoe (43) Pub
    US 201302241 10A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0224110 A1 Bynoe (43) Pub. Date: Aug. 29, 2013 (54) USE OF ADENOSINE RECEPTOR Publication Classification SIGNALING TO MODULATE PERMEABILITY OF BLOOD-BRAIN (51) Int. Cl. BARRIER A 6LX3 L/7076 (2006.01) A 6LX3/59 (2006.01) A6II 45/06 (2006.01) (75) Inventor: Margaret S. Bynoe, Ithaca, NY (US) A613 L/437 (2006.01) (52) U.S. Cl. CPC ........... A6 IK3I/7076 (2013.01); A61 K3I/437 (73) Assignee: CORNELL UNIVERSITY, Ithaca, NY (2013.01); A61 K3I/519 (2013.01); A61 K (US) 45/06 (2013.01) USPC ............ 424/1.49; 514/303: 514/45: 514/267; (21) Appl. No.: 13/823,266 424/649; 424/94.5; 424/133.1: 514/17.7: 514/8.6; 424/85.4; 424/143.1; 424/141.1; (22) PCT Fled: Sep. 16, 2011 424/147.1:435/375 (86) PCT NO.: PCT/US 11/51935 (57) ABSTRACT The present invention relates to a method of increasing blood S371 (c)(1), brain barrier (“BBB) permeability in a subject. This method (2), (4) Date: May 14, 2013 involves administering to the Subject an agentoragents which activate both of the A1 and A2A adenosine receptors. Also disclosed is a method to decrease BBB permeability in a Related U.S. Application Data Subject. This method includes administering to the Subject an agent which inhibits or blocks the A2A adenosine receptor (60) Provisional application No. 61/383,628, filed on Sep. signaling. Compositions relating to the same are also dis 16, 2010.
    [Show full text]